Sulica A, Galatiuc C, Manciulea M, Bancu A C, DeLeo A, Whiteside T L, Herberman R B
Department of Immunology, Victor Babes Institute, Bucharest, Romania.
Cell Immunol. 1993 Apr 1;147(2):397-410. doi: 10.1006/cimm.1993.1079.
The regulation of human natural killer (NK) activity by IgG described previously by us depends on the ability of cytophilic molecules of monomeric IgG (mIgG) to inhibit the subsequent killing of NK-sensitive targets. Highly purified NK cells obtained from human peripheral blood are able to directly bind mIgG as well as antigen-complexed IgG through its Fc region. The demonstration that NK cells bear labile cytophilic IgG, a property which usually has been attributed to L cells, indicates that mIgG-induced inhibition of NK activity is mediated by direct interactions between the inhibitory ligand and cytotoxic effector cells. The Fc receptor (FcR) mediating downregulation of NK cytotoxicity appeared to be FcR gamma III, previously found to be selectively expressed on NK cells and granulocytes. In studies of unidirectional cross-inhibition of mIgG binding to NK cells by various anti-CD16 monoclonal antibodies, binding characteristics of mIgG or complexed IgG were similar. Thus, the FcR gamma III for mIgG appear to be indistinguishable from receptors responsible for binding of polymeric IgG on human NK cells. The negative regulation of NK activity by mIgG was not attributable to inhibition of conjugate formation between effector cells and K532 targets, but rather to inhibition of a post-binding event involved in killing of conjugated targets. The data presented suggest that the Fc gamma RIII on human NK cells can either mediate killing against IgG antibody-coated target cells or, upon interaction with cytophilic monomeric ligand in soluble form, induce inhibition of NK activity.
我们之前描述的IgG对人类自然杀伤(NK)活性的调节作用取决于单体IgG(mIgG)的嗜细胞分子抑制随后对NK敏感靶标的杀伤能力。从人外周血中获得的高度纯化的NK细胞能够通过其Fc区域直接结合mIgG以及抗原复合物化的IgG。NK细胞带有不稳定的嗜细胞性IgG这一现象的证实,这种特性通常被认为是L细胞所具有的,表明mIgG诱导的NK活性抑制是由抑制性配体与细胞毒性效应细胞之间的直接相互作用介导的。介导NK细胞毒性下调的Fc受体(FcR)似乎是FcRγIII,之前发现它在NK细胞和粒细胞上选择性表达。在各种抗CD16单克隆抗体对mIgG与NK细胞结合的单向交叉抑制研究中,mIgG或复合物化IgG的结合特性相似。因此,mIgG的FcRγIII似乎与负责结合人NK细胞上聚合IgG的受体没有区别。mIgG对NK活性的负调节并非归因于效应细胞与K532靶标之间共轭形成的抑制,而是归因于对结合后参与杀伤共轭靶标的事件的抑制。所呈现的数据表明,人NK细胞上的FcγRIII既可以介导对IgG抗体包被靶细胞的杀伤,也可以在与可溶性形式的嗜细胞性单体配体相互作用时,诱导NK活性的抑制。